Abstract

This month we consider two European web sites that are of international interest. The first provides data on drug induced lung disease, the second collects and provides data on antimicrobial resistance in Europe. http://www.pneumotox.comBased in France, at the University Hospital in Dijon, the group running this web site collect together papers dealing with drug induced lung disease. On accessing the home page, the user can select which language they wish to use (a choice of English, French, or Spanish is provided). The home page also provides links to two different search methods. Firstly, the user can search by generic drug name; by the name alone, or with different patterns of lung damage that may occur. Alternatively, they may search by clinical or radiological pattern of lung involvement. Whichever search method is used, the user is provided with a list of published papers dealing with the drug in question and, as appropriate, lung conditions it has been associated with. It is stated on the web site that the list of papers provided is not necessarily exhaustive, but some indication is given of the number of known cases of association between the drug in question and the given condition. Although superficially this seems a simple web site, it in fact provides a wealth of useful information. Information is updated regularly, and a date on which the site was last updated (last month at the time of writing) is stated. Use of the web site is unrestricted and its content will be of interest to doctors and other healthcare professionals in a wide variety of disciplines.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.